Dianthus and An2 Therapeutics Directors Sell Over $500,000 in Stock

Simon Read, a director at Dianthus Therapeutics, sold $326,553 worth of stock, while Robin Readnour, a director at An2 Therapeutics, sold $212,701 in common stock.